Dr. Philip W. Perlman, MD

Dr. Perlman practices at ENT and Allergy Associates in Great Neck, New York.

Dr. Perlman's NPI, 1588604664, was assigned on June 7, 2006. Dr. Perlman graduated from SUNY Downstate Health Sciences University in 1983. Dr. Perlman holds New York license 158666.

Dr. Perlman's primary practice is ENT and Allergy Associates, at 333 E Shore Rd, Great Neck, NY 11023 in Nassau County. The practice phone is (914) 333-5800.

Dr. Perlman's primary practice is ENT and Allergy Associates in Great Neck, New York. Dr. Perlman is also affiliated with North Shore University Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Perlman to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perlman practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Perlman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Perlman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Perlman's licenses on file in 3 states: New York, New Jersey and Florida.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Perlman treats.

CMS data shows 2,730 Medicare services from Dr. Perlman across 12 procedure codes in 2024, for 1,104 Medicare patients. Medicare paid $274,479 for them. Every service was in an office.

CMS counts 1,104 Medicare patients who saw Dr. Perlman in 2024. The largest group is 75 to 84, with 438 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Perlman's median patient age at 60, with 52% women.

In 2024, Dr. Perlman wrote 1,190 Medicare Part D claims for 446 patients. 97% of them were for generic drugs. CMS names the drug for 1,119 of them, across 22 drugs with 11 or more claims each, at $30,424 in total drug cost. In 2023, CMS named 967 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Perlman for performance year 2024, reported as part of a group. Dr. Perlman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Perlman. The most frequent topics are Deglutition Disorders, Inhalation and Hypopharynx. Dr. Perlman has published most often in Otolaryngol Head Neck Surg. Dr. Perlman's most frequent co-authors are Michael Setzen, MD, Joel Guss, MD and Peter Charles Belafsky, MD, PhD.

CMS Open Payments shows 250 general payments to Dr. Perlman from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sanofi and Genzyme US Companies paid the most, $1,194.

Dmand AI lists 5 awards for Dr. Perlman, most recently Newsday - Top Doctors on Long Island in 2014.

Dr. Perlman graduated from SUNY Downstate Health Sciences University in 1983. Dr. Perlman is a member of NHS and ACS.

Dr. Perlman is in network with 13 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.